Adam DeVore
Adam DeVore
Duke University Medical Center
Verifierad e-postadress på duke.edu
Titel
Citeras av
Citeras av
År
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
AF Hernandez, JB Green, S Janmohamed, RB D'Agostino Sr, CB Granger, ...
The Lancet 392 (10157), 1519-1529, 2018
3932018
Angiotensin–neprilysin inhibition in acute decompensated heart failure
EJ Velazquez, DA Morrow, AD DeVore, CI Duffy, AP Ambrosy, ...
New England Journal of Medicine 380 (6), 539-548, 2019
2532019
Association of the hospital readmissions reduction program implementation with readmission and mortality outcomes in heart failure
A Gupta, LA Allen, DL Bhatt, M Cox, AD DeVore, PA Heidenreich, ...
JAMA cardiology 3 (1), 44-53, 2018
2072018
Heart failure with preserved, borderline, and reduced ejection fraction: 5-year outcomes
KS Shah, H Xu, RA Matsouaka, DL Bhatt, PA Heidenreich, AF Hernandez, ...
Journal of the American College of Cardiology 70 (20), 2476-2486, 2017
1782017
Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry
SJ Greene, J Butler, NM Albert, AD DeVore, PP Sharma, CI Duffy, CL Hill, ...
Journal of the American College of Cardiology 72 (4), 351-366, 2018
1432018
Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from Diuretic Optimization Strategy Evaluation in Acute Decompensated …
A Lala, SE McNulty, RJ Mentz, SM Dunlay, JM Vader, OF AbouEzzeddine, ...
Circulation: Heart Failure 8 (4), 741-748, 2015
1422015
Trends in 30-day readmission rates for patients hospitalized with heart failure: findings from the get with the guidelines-heart failure registry
KE Bergethon, C Ju, AD DeVore, NC Hardy, GC Fonarow, CW Yancy, ...
Circulation: Heart Failure 9 (6), e002594, 2016
932016
Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure
RJ Mentz, SR Stevens, AD DeVore, A Lala, JM Vader, OF AbouEzzeddine, ...
JACC: Heart Failure 3 (2), 97-107, 2015
772015
Association of 30-day readmission metric for heart failure under the hospital readmissions reduction program with quality of care and outcomes
A Pandey, H Golwala, H Xu, AD DeVore, R Matsouaka, M Pencina, ...
JACC: Heart Failure 4 (12), 935-946, 2016
602016
Titration of medical therapy for heart failure with reduced ejection fraction
SJ Greene, GC Fonarow, AD DeVore, PP Sharma, M Vaduganathan, ...
Journal of the American College of Cardiology 73 (19), 2365-2383, 2019
572019
Impaired left ventricular global longitudinal strain in patients with heart failure with preserved ejection fraction: insights from the RELAX trial
AD DeVore, S McNulty, F Alenezi, M Ersboll, JM Vader, JK Oh, G Lin, ...
European journal of heart failure 19 (7), 893-900, 2017
552017
Trends in noncardiovascular comorbidities among patients hospitalized for heart failure: insights from the Get With the Guidelines–Heart Failure Registry
A Sharma, X Zhao, BG Hammill, AF Hernandez, GC Fonarow, GM Felker, ...
Circulation: Heart Failure 11 (6), e004646, 2018
502018
Initiation, continuation, or withdrawal of angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers and outcomes in patients hospitalized with heart failure with …
LG Gilstrap, GC Fonarow, AS Desai, L Liang, R Matsouaka, AD DeVore, ...
Journal of the American Heart Association 6 (2), e004675, 2017
502017
Timing and causes of readmission after acute heart failure hospitalization—insights from the Heart Failure Network Trials
JM Vader, SJ LaRue, SR Stevens, RJ Mentz, AD DeVore, A Lala, ...
Journal of cardiac failure 22 (11), 875-883, 2016
502016
Torsemide versus furosemide in patients with acute heart failure (from the ASCEND-HF Trial)
RJ Mentz, V Hasselblad, AD DeVore, M Metra, AA Voors, PW Armstrong, ...
The American journal of cardiology 117 (3), 404-411, 2016
472016
Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
KK Ray, HM Colhoun, M Szarek, M Baccara-Dinet, DL Bhatt, VA Bittner, ...
The Lancet Diabetes & Endocrinology 7 (8), 618-628, 2019
442019
Temporal trends and factors associated with diabetes mellitus among patients hospitalized with heart failure: findings from Get With The Guidelines–Heart Failure registry
JB Echouffo-Tcheugui, H Xu, AD DeVore, PJ Schulte, J Butler, CW Yancy, ...
American heart journal 182, 9-20, 2016
442016
Has public reporting of hospital readmission rates affected patient outcomes?: analysis of Medicare claims data
AD DeVore, BG Hammill, NC Hardy, ZJ Eapen, ED Peterson, ...
Journal of the American College of Cardiology 67 (8), 963-972, 2016
442016
Body weight change during and after hospitalization for acute heart failure: patient characteristics, markers of congestion, and outcomes: findings from the ASCEND-HF trial
AP Ambrosy, LP Cerbin, PW Armstrong, J Butler, A Coles, AD DeVore, ...
JACC: Heart Failure 5 (1), 1-13, 2016
432016
In‐hospital worsening heart failure and associations with mortality, readmission, and healthcare utilization
AD DeVore, BG Hammill, PP Sharma, LG Qualls, RJ Mentz, ...
Journal of the American Heart Association 3 (4), e001088, 2014
412014
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20